Pharmacy staff who thought that selling syringes to injection drug users (IDUs) caused the community to be littered with dirty syringes were significantly less likely to support in-pharmacy HIV testing.

Conclusion: Support for in-pharmacy HIV testing was high among our sample of ESAP pharmacy staff actively involved in EGFR inhibitor nonprescription syringe sales. These findings suggest that active ESAP pharmacy staff may be amenable to providing HIV counseling and testing to IDUs and warrants further investigation.”
“This

study, the selective removal of limonin bitterness from Washington navel orange juice by batch adsorption to the Amberlite XAD-16HP and Dowex Optipore L285 was investigated and the determination of some compositional changes that occurred with orange juices debittering using adsorption check details resins were the primary focus. Amberlite XAD-16HP and Dowex Optipore L285 have been successfully used to reduce bitterness to acceptable levels in Washington navel orange juices. Amberlite XAD-16HP does not have any important negative effects on the quality characteristics of orange

juices. However, Dowex Optipore L285 reduces the titratable acidity (TA) in the orange juices and so increases the content of soluble solids contents (SSC), pH value, and ratio accordingly.”
“Objective: To better understand the occupational risks for substance use disorders among pharmacists and possibilities for improved prevention.

Design: Descriptive, nonexperimental, cross-sectional

study.

Setting: A southeastern state from December 2008 to April 2009.

Participants: 32 participants (72.7% men) from the impaired professionals monitoring groups in the geographic regions within the state that had the greatest number of physicians, pharmacists, and allied health professionals currently Selleck DMXAA under monitoring contracts for substance use disorders.

Intervention: Guided group discussions regarding substance use among health care providers.

Main outcome measures: Persistent occupational risks for development of a substance use disorder among pharmacists.

Results: Several occupational hazards unique to the pharmacy profession might contribute to the problem of substance use disorders among some members of this population, including increased access to potent drugs of abuse, a stressful/unpleasant working environment, a culture that unofficially condones medication diversion, lack of education related to addiction, and lack of support for individuals seeking treatment.

Conclusion: These results have important implications for the education of student pharmacists, the continuing education of licensed pharmacists, and the management of pharmacies in which these individuals work.